Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)
| CAPS Rating |
|
|---|---|
| Open | $44.91 |
| Previous Close | $44.94 |
| Daily Range | $44.60 - $45.15 |
| 52-Week Range | $35.00 - $52.35 |
| Market Cap | $39.75B |
| P/E Ratio | 10.90 |
| Dividend (Yield) | 0.79 (0.80%) |
| Volume | 3,812,606 |
| Average Daily Volume | 0 |
TEVA
VS S&P 500 (SPY)
How do you think TEVA will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
TEVA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
TEVA News and Commentary
- UPDATE: US Appeals Court Upholds Dismissal Of Some AstraZeneca Crestor Patent Suits – SmartMoney
- US Appeals Court Upholds Dismissal Of Some AstraZeneca Crestor Patent Lawsuits – SmartMoney
- 7 Hot Indian Stocks – Minyanville
- Shire and Sangamo Cut a Deal - Analyst Blog – NASDAQ
- What's Going on With These Biotech Stocks? – The Motley Fool
- The Disadvantage of a Successful Pipeline – The Motley Fool
- Checking the Quality of Teva's Growth – The Motley Fool
- Valeant Withdraws ISTA Offer - Analyst Blog – NASDAQ
- This Blockbuster Drug Just Got Better – The Motley Fool
- Teva Pharmaceutical's Dividend X-Ray – The Motley Fool
- Label Expansion for Merck KGaA Drug - Analyst Blog – NASDAQ
- Label Expansion for Merck KGaA Drug - Analyst Blog – NASDAQ
- 2 Stocks to Beat a Recession – The Motley Fool
- Teva Recalls 1 Batch Of Treanda Due To Presence Of Glass In Vial – SmartMoney
- Wall Street's Best Hidden Stocks – The Motley Fool
- Mylan Outperforms as Generics Rule - Analyst Blog – NASDAQ
- 13 Safest Foreign Dividend Stocks – Blog at The Motley Fool
- 50% of This Market Would Be Just Fine – The Motley Fool
- Investing In Israel – Blogs @ The Motley Fool
- Buy, Sell, or Hold: Cell Therapeutics – The Motley Fool
RSS Headlines
Fool UK
